Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Agostinetto

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Nature Reviews. Clinical Oncology|October 17, 2022
Systemic therapy for early-stage breast cancer: learning from the past to build the futureElisa Agostinetto, Joseph Gligorov, Martine Piccart
Cell Reports. Medicine|May 17, 2024
Emerging treatments in HER2-positive advanced breast cancer: Keep raising the barElisa Agostinetto, Giuseppe Curigliano, Martine Piccart
Current Opinion in Oncology|August 8, 2023
Circulating tumor DNA in breast cancer: a biomarker for patient selectionElisa Agostinetto, Guilherme Nader-Marta, Michail Ignatiadis
Recenti Progressi in Medicina|January 19, 2016
[Complementary and alternative medicine in oncology]Claudia Bozza, Elisa Agostinetto, Lorenzo Gerratana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2024
Axillary Surgery for Patients With Residual Isolated Tumor Cells (ypN0i+) After Neoadjuvant Systemic Therapy for Early Breast CancerElisa Agostinetto, Carmela Caballero, Michail Ignatiadis, et al.
Current Oncology Reports|March 25, 2021
Emerging Therapeutics for Patients with Triple-Negative Breast CancerElisa Agostinetto, Daniel Eiger, Kevin Punie, et al.
Cancers|April 3, 2021
The Exciting New Field of HER2-Low Breast Cancer TreatmentDaniel Eiger, Elisa Agostinetto, Rita Saúde-Conde, et al.
Expert Opinion on Therapeutic Targets|May 31, 2022
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targetsAlberto Zambelli, Riccardo Sgarra, Rita De Sanctis, et al.
Medicine|December 20, 2019
Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case reportRita De Sanctis, Elena Lorenzi, Elisa Agostinetto, et al.
Cancers|June 10, 2023
Hope and Hype around Immunotherapy in Triple-Negative Breast CancerFlavia Jacobs, Elisa Agostinetto, Chiara Miggiano, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Nature Reviews. Clinical Oncology|October 17, 2022
Systemic therapy for early-stage breast cancer: learning from the past to build the futureElisa Agostinetto, Joseph Gligorov, Martine Piccart
Cell Reports. Medicine|May 17, 2024
Emerging treatments in HER2-positive advanced breast cancer: Keep raising the barElisa Agostinetto, Giuseppe Curigliano, Martine Piccart
Current Opinion in Oncology|August 8, 2023
Circulating tumor DNA in breast cancer: a biomarker for patient selectionElisa Agostinetto, Guilherme Nader-Marta, Michail Ignatiadis
Recenti Progressi in Medicina|January 19, 2016
[Complementary and alternative medicine in oncology]Claudia Bozza, Elisa Agostinetto, Lorenzo Gerratana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2024
Axillary Surgery for Patients With Residual Isolated Tumor Cells (ypN0i+) After Neoadjuvant Systemic Therapy for Early Breast CancerElisa Agostinetto, Carmela Caballero, Michail Ignatiadis, et al.
Current Oncology Reports|March 25, 2021
Emerging Therapeutics for Patients with Triple-Negative Breast CancerElisa Agostinetto, Daniel Eiger, Kevin Punie, et al.
Cancers|April 3, 2021
The Exciting New Field of HER2-Low Breast Cancer TreatmentDaniel Eiger, Elisa Agostinetto, Rita Saúde-Conde, et al.
Expert Opinion on Therapeutic Targets|May 31, 2022
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targetsAlberto Zambelli, Riccardo Sgarra, Rita De Sanctis, et al.
Medicine|December 20, 2019
Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case reportRita De Sanctis, Elena Lorenzi, Elisa Agostinetto, et al.
Cancers|June 10, 2023
Hope and Hype around Immunotherapy in Triple-Negative Breast CancerFlavia Jacobs, Elisa Agostinetto, Chiara Miggiano, et al.
Pageof 8